PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Blocking protein control pathway slows rhabdomyosarcoma growth in mice

“Together, these findings confirm that proteostasis inhibition can slow RMS growth and suggest that targeting compensatory network components might yield synergistic outcomes”

2025-08-29
(Press-News.org)

“Together, these findings confirm that proteostasis inhibition can slow RMS growth and suggest that targeting compensatory network components might yield synergistic outcomes.”

BUFFALO, NY – August 29, 2025 – A new research paper was published in Volume 16 of Oncotarget on August 29, 2025, titled “In vivo manipulation of the protein homeostasis network in rhabdomyosarcoma.”

In this study led by first author Kristen Kwong and corresponding author Amit J. Sabnis from the Department of Pediatrics, Division of Oncology, University of California San Francisco, researchers discovered that disrupting the protein quality control system in cancer cells slows tumor growth in rhabdomyosarcoma (RMS), the most common pediatric soft tissue cancer. This finding points to a new strategy for treating high-risk childhood cancers that often resist current therapies.

Rhabdomyosarcoma is a rare and aggressive cancer that primarily affects children and adolescents. Standard treatments like chemotherapy and radiation often have limited long-term success in high-risk cases. This study explored a different approach: targeting the cellular machinery that maintains protein quality, known as the proteostasis network. Cancer cells rely heavily on this system to survive stress caused by rapid growth and genetic instability.

“To examine whether MAL3-101 or more drug-like proteostasis inhibitors represent a new therapeutic strategy for RMS, we screened proteostasis components that might recapitulate the effects of MAL3-101 in vivo.”

The researchers first used a compound called MAL3-101 to disrupt protein control in RMS cells. They then identified which parts of the protein quality system were affected. Based on those findings, they searched for more drug-like compounds that could target the same pathways. 

They focused on a protein called p97, which plays a critical role in removing damaged or misfolded proteins. When they blocked p97 using a drug called CB-5083, the cancer cells could no longer manage internal stress and began to self-destruct. In both laboratory models and mice implanted with human RMS tumors, the treatment significantly slowed or stopped tumor growth. The drug triggered a stress response in the cells known as the unfolded protein response, which can lead to either recovery or programmed cell death.

However, not all tumors responded the same way. Some resisted the treatment by activating a backup system called autophagy, which allows cells to recycle parts of themselves under stress. By comparing tumors that responded well to those that did not, the researchers found that higher autophagy activity could serve as a warning sign for resistance. This insight may help identify which patients are more likely to benefit from therapies that target protein quality control.

While the results are promising, the drug’s effectiveness depended on the tumor’s genetic profile and how it handled stress. Combining p97 inhibition with other treatments or blocking alternative survival pathways like autophagy may improve outcomes. The researchers also noted the importance of developing safer and more targeted drugs to reduce side effects.

This study opens new possibilities for personalized cancer treatment, particularly for children with aggressive or relapsed RMS. By weakening the systems that cancer cells depend on to survive, rather than only using toxic treatments to kill them, scientists aim to develop more effective and less harmful therapies for young patients.

Continue reading: DOI: https://doi.org/10.18632/oncotarget.28764

Correspondence to: Amit J. Sabnis – amit.sabnis@ucsf.edu 

Keywords: cancer, protein homeostasis, rhabdomyosarcoma, unfolded protein response, preclinical therapeutics, p97

Click here to sign up for free Altmetric alerts about this article.

About Oncotarget:  

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science).

To learn more about Oncotarget, visit Oncotarget.com and connect with us on social media:

X
Facebook
YouTube
Instagram
LinkedIn
Pinterest
Spotify, and available wherever you listen to podcasts

Click here to subscribe to Oncotarget publication updates.

For media inquiries, please contact media@impactjournals.com.  

END



ELSE PRESS RELEASES FROM THIS DATE:

2026 Hertz Fellowship Application Now Open

2025-08-29
The Hertz Foundation, a nonprofit dedicated to advancing American scientific and technological leadership, today announced that the application for the 2026 Hertz Fellowship is now open. The Hertz Fellowship is one of the most competitive and coveted awards for doctoral students in applied sciences, engineering and mathematics. Hertz Fellows receive up to five years of funding, giving them freedom from the traditional constraints of graduate training and the independence needed to pursue groundbreaking research. They also gain lifelong professional support, including mentoring, events and networking opportunities. Hertz Fellows join ...

The gut immune system is altered in mouse model of Alzheimer’s, providing a new target for therapeutics

2025-08-29
The gut contains the largest collection of immune cells in the body. New research at the Buck Institute shows that some of those immune cells travel along the brain/gut axis in a mouse model of Alzheimer’s disease (AD) providing a potential new therapeutic pathway for the memory-robbing malady. The research, published in the August29, 2025 issue of Cell Reports, also shows that feeding the mice a high fiber diet reduces AD-related frailty, including tremor. “This paper brings the gut immune system to the forefront of neurodegenerative disease pathology,” says ...

ADHD drugs are being prescribed too quickly to preschoolers

2025-08-29
Young children with attention deficit/hyperactivity disorder often receive medication just after being diagnosed, which contravenes treatment guidelines endorsed by the American Academy of Pediatrics, a Stanford Medicine-led study has found. The finding, which will be published Aug. 29 in JAMA Network Open, highlights a gap in medical care for 4- and 5-year-olds with ADHD. Treatment guidelines recommend that these young children and their families try six months of behavior therapy before starting ADHD medication. But pediatricians ...

UCLA scientists develop off-the-shelf immunotherapy for metastatic kidney cancer

2025-08-29
UCLA researchers have developed a new kind of immunotherapy that uses specially engineered immune cells equipped with built-in weapons to attack kidney cancer tumors and reprogram their protective environment — all without the need to customize treatment for each individual patient. This “off-the-shelf” approach, called AlloCAR70-NKT, could help improve outcomes, reduce complications and expand access for patients with limited treatment options.  “We successfully turned stem cells into powerful cancer-fighting immune cells that can be ready to use for any patient, bypassing the ...

Extreme heat linked to spike in domestic violence calls in New Orleans, study finds

2025-08-29
Prolonged extreme heat in New Orleans was linked to a measurable increase in domestic violence-related emergency calls, according to new research in JAMA Open Network co-authored by the Tulane University’s Newcomb Institute. The study analyzed more than 150,000 domestic violence (DV) calls made to the New Orleans Police Department from 2011 to 2021. Researchers found that when “feels-like” temperatures factoring in heat and humidity stayed in the city’s top 10% for at least five straight days, domestic violence ...

Mount Sinai-Duke University study identifies DNA variants that increase testosterone production in PCOS patients

2025-08-29
Journal: Nature Communications Title: Gene Regulatory Activity Associated with Polycystic Ovary Syndrome Reveals DENND1A-Dependant Testosterone Production Authors: Andrea Dunaif, MD, Chief of the Division of Endocrinology, Diabetes and Bone Disease for the Mount Sinai Health System and the Lillian and Henry M. Stratton Professor of Molecular Medicine at the Icahn School of Medicine at Mount Sinai Bottom line: Increased testosterone levels are a consistent hormonal abnormality in women with polycystic ovary syndrome (PCOS). This study identified specific DNA variants in the gene DENND1A, which increase testosterone production in PCOS. Using human PCOS cell models, researchers ...

Physiology-guided complete revascularization in older patients with myocardial infarction

2025-08-29
About The Study: In patients 75 years or older with myocardial infarction and multivessel disease, the benefit of physiology-guided complete revascularization over culprit-lesion–only treatment was sustained at 3 years.  Corresponding Author: To contact the corresponding author, Simone Biscaglia, MD, email bscsmn@unife.it.  To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ Editor’s Note: Please see the article for additional information, including other authors, ...

Metals and sulfate in air pollution mixture may contribute most to asthma hospitalizations

2025-08-29
Embargoed for release: Friday, August 29, 2025, 9:00 AM ET Key points: Nickel, vanadium, sulfate, nitrate, bromine, and ammonium are the components of fine particulate air pollution (PM2.5) that contribute most to the association between long-term exposure to air pollution and asthma hospitalization. Prior research has examined the relationship between asthma and individual pollutants or PM2.5 as a whole. This study teases out which compounds within the PM2.5 mixture are most harmful. The study can inform ...

Understanding the profound yet hidden effects of neglect on white matter structures

2025-08-29
When we think of child abuse, physical violence or emotional cruelty often comes to mind first. However, the most common form of maltreatment is actually much quieter: neglect. Affecting three out of four children in substantiated abuse cases worldwide, child neglect involves the failure to provide basic necessities like adequate food, shelter, supervision, or protection. Despite causing documented long-term mental health problems and developmental issues, this ‘invisible’ form of maltreatment has received surprisingly little ...

SEOULTECH researchers develop revolutionary 3D-printed smart materials create high-performance pressure sensors for wearables

2025-08-29
Tactile sensors are widely used in robotics, prosthetics, wearable devices, and healthcare monitoring. These devices detect and convert external stimuli such as pressure and force into electrical signals, facilitating effective environmental detection. Scientists have made extensive efforts to improve the performance of tactile sensors in terms of sensing range and sensitivity. In this context, mechanical metamaterials are highly promising. Specifically, auxetic mechanical metamaterials (AMMs)—possessing ...

LAST 30 PRESS RELEASES:

Crosswalk confusion: MA drivers flummoxed by pedestrian hybrid beacons, find UMass Amherst researchers

Study shows heart disease mortality disproportionately burdens low-income communities in California

Intracardiac echocardiography recognized as ‘transformative’ imaging modality in new SCAI position statement

Study finds ‘man’s best friend’ slows cellular aging in female veterans

To get representative health data, researchers hand out fitbits

Hiring in high-growth firms: new study explores the timing of organizational changes

Boosting work engagement through a simple smartphone diary

Climate change may create ‘ecological trap’ for species who can’t adapt

Scientists create ChatGPT-like AI model for neuroscience to build one of the most detailed mouse brain maps to date

AI and omics unlock personalized drugs and RNA therapies for heart disease

2023 ocean heatwave ‘unprecedented but not unexpected’

Johns Hopkins researchers develop AI to predict risk of US car crashes

New drug combination offers hope for men with advanced prostate cancer

New discovery finds gene converts insulin-producing cells into blood-sugar boosters

Powerful and precise multi-color lasers now fit on a single chip

Scientists agree chemicals can affect behavior, but industry workers more reluctant about safety testing

DNA nanospring measures cellular motor power

Elsevier Foundation and RIKEN launch “Envisioning Futures” report: paving the way for gender equity and women’s leadership in Japanese research

Researchers discover enlarged areas of the spinal cord in fish, previously found only in four-limbed vertebrates

Bipolar disorder heterogeneity decoded: transforming global psychiatric treatment approaches

Catching Alport syndrome through universal age-3 urine screening

Instructions help you remember something better than emotions or a good night’s sleep

Solar energy is now the world’s cheapest source of power, a Surrey study finds

Scientists reverse Alzheimer’s in mice using nanoparticles

‘Good’ gut bacteria boosts placenta for healthier pregnancy

USC team demonstrates first optical device based on “optical thermodynamics”

Microplastics found to change gut microbiome in first human-sample study

Artificially sweetened and sugary drinks are both associated with an increased risk of liver disease, study finds

Plastic in the soil, but not as we know it: Biodegradable microplastics rewire carbon storage in farm fields

Yeast proteins reveal the secrets of drought resistance

[Press-News.org] Blocking protein control pathway slows rhabdomyosarcoma growth in mice
“Together, these findings confirm that proteostasis inhibition can slow RMS growth and suggest that targeting compensatory network components might yield synergistic outcomes”